The University of Cincinnati College of Medicine is collaborating with Johns Hopkins University on new COVID-19 studies.
The universities are working together to assess the effectiveness of convalescent blood plasma as an outpatient therapy for COVID-19 treatment and prevention.
Sign up for our Newsletters
This is the first U.S. multi-center, double-blind, randomized clinical trial.
Both universities will do these studies to find out how this trial differs from other plasma trials and how it affects the body in people all over the world.
The trials will be held at the University of Cincinnati College of Medicine.
Anyone who has been recently exposed, newly diagnosed with coronavirus and have symptoms can fill out a questionnaire online or call Johns Hopkins University at 888-506-1199. You can click here to find the questionnaire online.
Participants will be paid in this study.
You can find out more information on the website to see if you qualify for this study.
READ THE FULL STORY:UC College of Medicine collaborates with Johns Hopkins University on new COVID-19 studies
CHECK OUT WLWT:Stay in the know. Get the latest Cincinnati news, weather and sports from the team at Ohio’s own WLWT.